Notice: This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesInsider TradesOwnershipTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Hunterbrook Capital long Bioage Labs, Hunterbrook Media reportsDecember 20 at 1:05 PM | tipranks.comBIOA INVESTIGATION NEWS: An Investigation has been Initiated on behalf of BioAge Labs Shareholders -- Contact BFA Law if You Suffered Losses (NASDAQ:BIOA)December 20 at 7:41 AM | globenewswire.comBioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens BermanDecember 19 at 1:15 PM | globenewswire.comBIOA SHAREHOLDER REPORT: BioAge Labs Investors are Notified the Company is Being Investigated and are Urged to Contact BFA LawDecember 19 at 8:06 AM | markets.businessinsider.comBioAge, Novartis team up to discover age-related disease targetsDecember 18, 2024 | msn.comBioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and ConditionsDecember 18, 2024 | globenewswire.comBIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of BioAge Stockholders and Encourages Investors to Contact the FirmDecember 17, 2024 | globenewswire.comKirby McInerney LLP Announces Investigation Against BioAge Labs, Inc. (BIOA) on Behalf of InvestorsDecember 17, 2024 | globenewswire.comBIOA INVESTOR NEWS: BioAge Labs, Inc. Investors with Losses are Notified of Continuing Investigation and are Urged to Contact BFA LawDecember 16, 2024 | markets.businessinsider.comBioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens BermanDecember 16, 2024 | globenewswire.comBIOA INVESTOR NOTICE: BioAge Labs is being Investigated after Discontinuing its Phase 2 Trials -- Contact BFA Law (NASDAQ:BIOA)December 16, 2024 | globenewswire.comBIOA INVESTOR ALERT: BioAge Labs Investors are Alerted of Ongoing Investigation into the 76% Stock Drop and are Encouraged to Contact BFA LawDecember 15, 2024 | markets.businessinsider.comBIOA SHAREHOLDER ALERT: BFA Law Notifies BioAge Labs, Inc. Investors to Contact the Firm about its Ongoing InvestigationDecember 14, 2024 | markets.businessinsider.comBIOA INVESTOR ALERT: BioAge Labs Investors Should Contact Block & Leviton To Learn More About Fraud InvestigationDecember 12, 2024 | markets.businessinsider.comBioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens BermanDecember 12, 2024 | globenewswire.comBIOA INVESTIGATION ALERT: BFA Law Alerts BioAge Labs, Inc. Investors of its Ongoing Investigation – Contact the Firm if You Incurred Losses (NASDAQ:BIOA)December 12, 2024 | globenewswire.comBiotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & MoreDecember 11, 2024 | msn.comSHAREHOLDER ALERT: Investigation of BioAge Labs, Inc. (BIOA) Announced by Holzer & Holzer, LLCDecember 11, 2024 | globenewswire.comBIOA BREAKING NEWS: BFA Law Announces an Investigation into BioAge Labs, Inc. after Stock Plummets 76% -- Contact the Firm if You Lost Money (NASDAQ:BIOA)December 10, 2024 | globenewswire.comBioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover LossesDecember 10, 2024 | globenewswire.comBioAge Labs: Strategic Advancements and Long-term Potential Amidst SetbacksDecember 10, 2024 | markets.businessinsider.comRichmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trialDecember 10, 2024 | bizjournals.comBIOA Investors Have Opportunity to Join BioAge Labs, Inc. Securities Fraud Investigation with the Schall Law FirmDecember 10, 2024 | businesswire.comJefferies Downgrades BioAge Labs (BIOA)December 9, 2024 | msn.comCitigroup Downgrades BioAge Labs (BIOA)December 9, 2024 | msn.comBioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens BermanDecember 9, 2024 | globenewswire.comBioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market SessionDecember 9, 2024 | benzinga.comBioAge Labs downgraded to Neutral from Buy at CitiDecember 9, 2024 | tipranks.comBioAge Plunges Over 60% — What's Weighing Down The STRIDES Trial Of Its Obesity Drug?December 7, 2024 | markets.businessinsider.comBioAge stock craters 75% on obesity drug study halt (update)December 7, 2024 | msn.comBioAge Labs discontinues STRIDES phase 2 clinical trialDecember 6, 2024 | tipranks.comBIOAGE Labs Inc trading resumesDecember 6, 2024 | tipranks.comBioAge discontinues mid-stage trial of obesity drugDecember 6, 2024 | reuters.comBioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of ObesityDecember 6, 2024 | globenewswire.comBioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst ClinicDecember 5, 2024 | globenewswire.comFirst patient dosed in EXIST Phase 2a study in Parkinson's diseaseDecember 5, 2024 | finance.yahoo.comLeqembi® launched in South KoreaNovember 28, 2024 | finance.yahoo.comBioAge Labs to Present at Upcoming Investor ConferencesNovember 21, 2024 | globenewswire.comCHMP issues positive recommendation for approval of lecanemab in the EUNovember 14, 2024 | finance.yahoo.comEisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billionNovember 8, 2024 | finance.yahoo.comBioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 7, 2024 | globenewswire.comBrainTransporter™ dramatically improves antibody delivery to the brainNovember 7, 2024 | uk.finance.yahoo.comInvitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CETNovember 7, 2024 | finance.yahoo.comEisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the USNovember 1, 2024 | finance.yahoo.comBioArctic: Professor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's DiseaseOctober 30, 2024 | finanznachrichten.deLeqembi® revenue totaled JPY 10 billion in the third quarter 2024October 30, 2024 | finance.yahoo.comProfessor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's DiseaseOctober 30, 2024 | finance.yahoo.comBioAge Labs to Present at Jefferies London Healthcare ConferenceOctober 25, 2024 | finance.yahoo.comLifetime Achievement Award, lecanemab and biomarkers in focus at CTADOctober 24, 2024 | uk.finance.yahoo.comBioAge Labs intiated with a Not Rated at Goldman SachsOctober 22, 2024 | msn.com Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. BIOA Media Mentions By Week BIOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOA News Sentiment▼0.000.60▲Average Medical News Sentiment BIOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOA Articles This Week▼122▲BIOA Articles Average Week Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mineralys Therapeutics News Terns Pharmaceuticals News ORIC Pharmaceuticals News Savara News Phathom Pharmaceuticals News Ironwood Pharmaceuticals News Annexon News Astria Therapeutics News PureTech Health News AnaptysBio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIOA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOA Stock Alerts